TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.

Robin K Avery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.